drugset / Trial / NCT02880410

Feasibility Study on LITT for Newly Diagnosed Glioblastoma

NCT02880410

Phase 1 Terminated 3 enrolled Monteris Medical
NaSingle-groupOpen-labelTreatment

Summary

Multicenter, open-label, prospective designed study to characterize the performance of brain laser interstitial thermal therapy (LITT) ablation using the Monteris NeuroBlate System in combination with standard of care radiation therapy and temozolomide for the treatment of newly diagnosed glioblastomas (GBM).

Timeline

Start
2017-08-15
Primary completion
2018-09-14
Completion
2018-09-14

Drugs

EvaluationDrugModalityDoseRoute
Background Temozolomide Small molecule

Indications